RMB Capital Management LLC lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 20.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 74,645 shares of the healthcare conglomerate’s stock after buying an additional 12,920 shares during the quarter. RMB Capital Management LLC’s holdings in UnitedHealth Group were worth $18,214,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in the company. Truvvo Partners LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth about $706,000. US Bancorp DE grew its position in shares of UnitedHealth Group by 5.0% during the second quarter. US Bancorp DE now owns 1,202,388 shares of the healthcare conglomerate’s stock worth $293,396,000 after buying an additional 56,956 shares in the last quarter. Greenwich Wealth Management LLC grew its position in shares of UnitedHealth Group by 0.5% during the second quarter. Greenwich Wealth Management LLC now owns 20,678 shares of the healthcare conglomerate’s stock worth $5,046,000 after buying an additional 96 shares in the last quarter. ETRADE Capital Management LLC grew its position in shares of UnitedHealth Group by 3.4% during the second quarter. ETRADE Capital Management LLC now owns 54,799 shares of the healthcare conglomerate’s stock worth $13,372,000 after buying an additional 1,798 shares in the last quarter. Finally, Chilton Capital Management LLC grew its position in shares of UnitedHealth Group by 30.9% during the second quarter. Chilton Capital Management LLC now owns 82,361 shares of the healthcare conglomerate’s stock worth $20,097,000 after buying an additional 19,419 shares in the last quarter. 86.04% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have recently commented on UNH shares. Oppenheimer set a $312.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Thursday, August 29th. Zacks Investment Research upgraded UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price for the company in a research note on Monday, July 22nd. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, September 5th. Finally, Deutsche Bank assumed coverage on UnitedHealth Group in a research note on Thursday. They set a “hold” rating and a $263.00 target price for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $292.47.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. During the same quarter in the previous year, the business earned $3.14 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Inc will post 14.84 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is currently 33.54%.
In other news, Director Richard T. Burke sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $231.50, for a total value of $463,000.00. Following the transaction, the director now owns 187,979 shares of the company’s stock, valued at $43,517,138.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the transaction, the director now directly owns 187,979 shares in the company, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,000 shares of company stock valued at $4,758,720. 0.87% of the stock is owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What are the disadvantages of after-hours trading?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.